Literature DB >> 8304502

Interstitial exclusion of IgG in rat tissues estimated by continuous infusion.

H Wiig1, G A Kaysen, H A al-Bander, M De Carlo, L Sibley, E M Renkin.   

Abstract

Interstitial exclusion, defined as the fraction of interstitial fluid volume inaccessible to a solute, was evaluated for immunoglobulin G (IgG) in selected tissues of rats by a method previously applied to serum albumin (29). IgG distribution volumes were also measured for intestine. 125I-labeled rat IgG was infused for 5 or 7 days (n = 4 rats each) with an implanted osmotic pump (Alzet). At the termination of infusion, the rat was anesthetized, nephrectomized, and injected with 51Cr-labeled EDTA (4 h) to label total extracellular fluid volume and 131I-labeled bovine IgG (5 min) to label plasma volume. Samples of skin, muscle, and tendon were assayed for total and extractable tracer activity. Interstitial fluid from these tissues was sampled postmortem with nylon wicks for assay of 125I-labeled IgG and endogenous albumin and IgG. Exclusion of IgG was calculated from the difference between extravascular 125I-labeled IgG and 51Cr-labeled EDTA distribution volumes. In contrast to our previous experience with tracer albumin, 125I-labeled IgG was not fully extractable from minced skin, muscle, or tendon by isotonic saline; only 71-83% was recovered under conditions that eluted 92-96% of tracer albumin and 94-99% of tracer EDTA. We conclude that approximately 20% of extravascular 125I-labeled IgG in these tissues is sequestered or bound in the interstitium. Calculation of IgG fractional exclusion from extractable tracer yielded the following values (means +/- SE, n = 8 rats): leg muscles 0.37 +/- 0.09, leg skin 0.44 +/- 0.03, back skin 0.36 +/- 0.04, tail skin 0.40 +/- 0.08, and tail tendon 0.55 +/- 0.04.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8304502     DOI: 10.1152/ajpheart.1994.266.1.H212

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Effect of charge on interstitial distribution of albumin in rat dermis in vitro.

Authors:  Helge Wiig; Odd Kolmannskog; Olav Tenstad; Joel L Bert
Journal:  J Physiol       Date:  2003-05-23       Impact factor: 5.182

2.  Second-generation minimal physiologically-based pharmacokinetic model for monoclonal antibodies.

Authors:  Yanguang Cao; Joseph P Balthasar; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-08-31       Impact factor: 2.745

3.  Survey of monoclonal antibody disposition in man utilizing a minimal physiologically-based pharmacokinetic model.

Authors:  Yanguang Cao; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-08-22       Impact factor: 2.745

4.  Effect of hydration on interstitial distribution of charged albumin in rat dermis in vitro.

Authors:  Helge Wiig; Olav Tenstad; Joel L Bert
Journal:  J Physiol       Date:  2005-10-06       Impact factor: 5.182

5.  Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain.

Authors:  Jan Terje Andersen; Rikard Pehrson; Vladimir Tolmachev; Muluneh Bekele Daba; Lars Abrahmsén; Caroline Ekblad
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

6.  In vivo determination of steric and electrostatic exclusion of albumin in rat skin and skeletal muscle.

Authors:  Christina C Gyenge; Olav Tenstad; Helge Wiig
Journal:  J Physiol       Date:  2003-08-22       Impact factor: 5.182

7.  Role of Interstitial Fluid Turnover on Target Suppression by Therapeutic Biologics Using a Minimal Physiologically Based Pharmacokinetic Model.

Authors:  Xiaobing Li; William J Jusko; Yanguang Cao
Journal:  J Pharmacol Exp Ther       Date:  2018-07-12       Impact factor: 4.030

8.  Interstitial exclusion of albumin in rabbit lung during development of pulmonary oedema.

Authors:  Daniela Negrini; Olav Tenstad; Helge Wiig
Journal:  J Physiol       Date:  2003-03-21       Impact factor: 5.182

9.  Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies.

Authors:  Yanguang Cao; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-07-31       Impact factor: 2.745

10.  The pharmacokinetics of the interstitial space in humans.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2003-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.